Next-generation safety database with AI automation
Regulatory, medical writing and pharmacovigilance Announcement
Disclosed: Verified:
Daiichi Sankyo says that, going forward, it is renewing its safety database into a next-generation database that incorporates automation by AI, in order to make global pharmacovigilance operations more efficient and to strengthen analysis.
Source
Company Archive pending